EFORT(SH:688165)2025-04-29 15:45Financial Performance - The company's revenue for Q1 2025 was CNY 252.28 million, a decrease of 24.71% compared to CNY 335.06 million in the same period last year[3]. - The net loss attributable to shareholders was CNY 67.36 million, compared to a loss of CNY 19.38 million in the previous year, representing an increase in loss of 247.63%[3][8]. - The weighted average return on equity was -4.23%, compared to -1.09% in the previous year, indicating a decline in profitability[3][8]. - Operating profit for Q1 2025 was a loss of CNY 98.23 million, compared to a loss of CNY 28.30 million in Q1 2024[18]. - Net profit for Q1 2025 was a loss of CNY 83.90 million, compared to a loss of CNY 20.24 million in Q1 2024[19]. - Total operating costs for Q1 2025 were CNY 353.08 million, down 7% from CNY 379.60 million in Q1 2024[18]. - Cash received from sales and services in Q1 2025 was CNY 280.53 million, down from CNY 347.06 million in Q1 2024[20]. - The company's equity attributable to shareholders decreased from CNY 1.61 billion to CNY 1.58 billion[15]. Cash Flow and Assets - The net cash flow from operating activities was negative CNY 73.78 million, worsening from a negative CNY 7.36 million in the same period last year[3][8]. - Total cash inflow from investment activities was $662.31 million, up from $131.17 million year-over-year[21]. - The net cash flow from investment activities was -$104.45 million, compared to -$9.08 million in the previous period[21]. - Cash inflow from financing activities was $110.70 million, down from $238.77 million year-over-year[21]. - The total cash and cash equivalents at the end of the period were $660.03 million, down from $684.88 million[21]. - The total assets at the end of the reporting period were CNY 3.56 billion, a decrease of 2.29% from CNY 3.64 billion at the end of the previous year[3]. - Total current assets as of March 31, 2025, amount to ¥2,461,305,258.02, a decrease from ¥2,579,694,356.02 as of December 31, 2024[13]. - Cash and cash equivalents are reported at ¥664,416,281.41, down from ¥787,649,177.22[13]. - Accounts receivable decreased to ¥853,901,384.57 from ¥935,813,863.81[13]. - Inventory increased to ¥281,218,268.16 from ¥260,602,894.87[13]. - The company has a total of 202,099,951.39 in long-term equity investments as of March 31, 2025[13]. Research and Development - R&D investment totaled CNY 41.16 million, an increase of 77.57% year-over-year, accounting for 16.32% of revenue, up 9.40 percentage points from the previous year[3][8]. - Research and development expenses increased to CNY 40.82 million in Q1 2025, compared to CNY 23.01 million in Q1 2024, reflecting a 77.5% increase[18]. - The company achieved a significant milestone in its general technology platform for intelligent robots by the end of February 2025, marking a step towards embodied intelligence[6][7]. - The company plans to maintain its strategic focus on embodied intelligence and expand its market presence despite short-term performance fluctuations[7]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 33,857[10]. - The largest shareholder, Wuhu Yuanhong Industrial Robot Investment Co., Ltd., holds 84,000,000 shares, accounting for 16.10% of total shares[10]. - The second largest shareholder, Wuhu Yuanda Venture Capital Co., Ltd., holds 65,818,276 shares, representing 12.61%[10]. - The company has not reported any significant changes in shareholder relationships or actions regarding share lending[11]. Other Information - Government subsidies recognized in the current period decreased compared to the previous year, impacting the overall financial performance[8]. - No new strategies or product developments were mentioned in the conference call[12]. - The basic and diluted earnings per share for Q1 2025 were both CNY -0.13, compared to CNY -0.04 in Q1 2024[19]. - The company will not apply new accounting standards starting from 2025[22].